Press Releases

1-for-8 Reverse Split Effective Wednesday; Shares to Trade Temporarily Under the Symbol "CEMID"

1-for-8 Reverse Split Effective Wednesday; Shares to Trade Temporarily Under the Symbol "CEMID"

Company Voices Support for FDA Blood Products Advisory Committee's Unanimous Recommendation in Favor of In-Home Rapid HIV Tests

Chembio to Present at the B. Riley 13th Annual Investor Conference MEDFORD, NY, May 17, 2012 (MARKETWIRE via COMTEX) --Chembio Diagnostics, Inc. (OTCQB: CEMI) (PINKSHEETS: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, today announced that its Chief

Record Product Sales More Than Double Over Prior Year; Conference Call Begins at 10:00 a.m. Eastern Time Today

Chembio to Present at Taglich Brothers Small Cap Equity Conference Tomorrow MEDFORD, NY, Apr 30, 2012 (MARKETWIRE via COMTEX) --Chembio Diagnostics, Inc. (OTCQB: CEMI) (PINKSHEETS: CEMI), a company that develops, manufactures, markets and licenses point-of-care diagnostic tests, today announced

Conference Call Scheduled for Tuesday, May 8th at 10:00 a.m. Eastern Time

Expects to File Final PMA Module With the FDA in June

Chembio Diagnostic Systems, Inc. to Present at Taglich Brothers 9th Annual Small Cap Equity Conference NEW YORK, NY, Apr 17, 2012 (MARKETWIRE via COMTEX) --Taglich Brothers, Inc. is pleased to announce that Lawrence A. Siebert, President & CEO of Chembio Diagnostic Systems, Inc.

Conference Call Begins at 10:00 a.m. Eastern Time Today